| Name | Title | Contact Details |
|---|
HPS Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
CCT is a pioneer in the QTc field. We conducted our first study in 1998 with Pfizer's ziprasidone in patients with schizophrenia. Our staff includes experienced principal investigators, dedicated cardiologists, psychiatrists, experienced ECG
Canadian Federation of Biological Societies is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CTMS Inc. is a Bristol, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.